The PHG Foundation's Caroline Wright and her colleagues discuss the next steps for whole-genome sequencing in the clinic and make "specific recommendations for prompt and effective adoption within the UK National Health Service" in a new report. Funded by the foundation and with support from Illumina, Wright and her colleagues examined how advances in whole-genome sequencing and bioinformatic analysis pipelines show potential for applications in diseases like cancer; the ethical, legal, and social implications of such applications; the economics of sequencing in a health-care setting; and present policy recommendations. In a sign of the times, the PHG Foundation group added the following disclaimer to its report, released this week:
What's Next for NGS?
Oct 26, 2011